IV Laser Therapy (2-Colour)

Intravenous laser blood irradiation using 2 wavelengths simultaneously. A thin fibre-optic catheter is introduced into a peripheral vein, delivering low-level laser light directly to the circulating blood for 30 minutes.

Intravenous laser blood irradiation (ILBI) is a photobiomodulation technique developed in the former Soviet Union in the 1980s and now widely practised across Central and Eastern European integrative medicine. Unlike transcutaneous (external) laser therapy, ILBI delivers laser light directly into the bloodstream via a sterile, single-use fibre-optic catheter inserted into a peripheral vein. This bypasses the significant photon attenuation that occurs when laser light must penetrate skin, subcutaneous fat, and muscle to reach blood vessels. The 2-colour protocol at Burnout-Praxis Berlin uses two laser wavelengths simultaneously, each targeting different chromophores in blood components. Red wavelengths (typically 635nm) are absorbed primarily by haemoglobin and cytochrome c oxidase in mitochondria, improving oxygen transport capacity and cellular respiration. Blue or green wavelengths target porphyrins and flavoproteins, with documented effects on immune cell activation and antimicrobial photodynamic mechanisms. The photobiological effects are dose-dependent and cumulative. A single 30-minute session delivers a standardised light dose to a significant fraction of the circulating blood volume (the entire blood volume passes through the irradiation point multiple times during the session). Clinical applications include chronic fatigue, post-viral syndromes, wound healing support, chronic pain conditions, and general immunomodulation. At €99 per session, the 2-colour IV laser sits between the simpler single-wavelength protocols offered at some clinics and the more comprehensive 4-colour option also available at Burnout-Praxis Berlin. Patients often begin with the 2-colour protocol and upgrade to 4-colour for subsequent treatment courses based on clinical response.